DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)

MANUFACTURER: Alnylam Pharmaceuticals

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Givlaari (givosiran) is a medication used to treat acute hepatic porphyria in adult patients and children over the age of 12.